Results overview: Found 4 records in 0.02 seconds.
Articles, 4 records found
Articles 4 records found  
1.
16 p, 3.2 MB Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer : A Systematic Review and Network Meta-analysis / Laukhtina, Ekaterina (Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia) ; Shim, Sung Ryul (Department of Preventive Medicine. Korea University College of Medicine) ; Mori, Keiichiro (Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan) ; D'Andrea, David (Department of Urology. Comprehensive Cancer Center. Medical University of Vienna) ; Soria, Francesco (Division of Urology. Department of Surgical Sciences. San Giovanni Battista Hospital. University of Studies of Torino) ; Rajwa, Pawel (Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Medical University of Silesia, Zabrze, Poland) ; Mostafaei, Hadi (Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran) ; Compérat, Eva (Department of Pathology. Comprehensive Cancer Center. Medical University of Vienna) ; Cimadamore, Alessia (Section of Pathological Anatomy. Marche Polytechnic University. School of Medicine. United Hospitals) ; Moschini, Marco (Department of Urology and Division of Experimental Oncology. Urological Research Institute. Vita-Salute San Raffaele) ; Teoh, Jeremy Yuen-Chun (S.H. Ho Urology Centre. Department of Surgery. Chinese University of Hong Kong) ; Enikeev, Dmitry (Institute for Urology and Reproductive Health. Sechenov University) ; Xylinas, Evanguelos (Department of Urology. Bichat-Claude Bernard Hospital. Assistance-Publique-Hôpitaux de Paris. Université de Paris) ; Lotan, Yair (Department of Urology. University of Texas Southwestern. TX) ; Palou, Juan (Institut d'Investigació Biomèdica Sant Pau) ; Gontero, Paolo (Division of Urology. Department of Surgical Sciences. San Giovanni Battista Hospital. University of Studies of Torino) ; Babjuk, Marko (Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic) ; Witjes, Johannes Alfred M. (Department of Urology. Radboud University) ; Kamat, Ashish Madhav (Department of Urology. M.D. Anderson Cancer Center. University of Texas. TX) ; Roupret, Morgan (Urology. Ap-Hp. Hôpital Pitié-Salpêtrière. Sorbonne Université) ; Shariat, Shahrokh F (Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia; Department of Urology, Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan) ; Pradere, Benjamin (Department of Urology. Comprehensive Cancer Center. Medical University of Vienna) ; Universitat Autònoma de Barcelona
CONTEXT: During the past decade, several urinary biomarker tests (UBTs) for bladder cancer have been developed and made commercially available. However, none of these is recommended by international guidelines so far. [...]
2021 - 10.1016/j.euo.2021.10.003
European urology oncology, Vol. 4 Núm. 6 (january 2021) , p. 927-942  
2.
20 p, 1.0 MB Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma : A Proposal for Standardization of Quality Care Metrics / König, Frederik (University Medical Center Hamburg-Eppendorf, Hamburg, Germany) ; Grossmann, Nico C. (Luzerner Kantonsspital, Lucerne, Switzerland) ; Soria, Francesco (San Giovanni Battista Hospital) ; D'Andrea, David (Medical University of Vienna, Vienna, Austria) ; Juvet, Tristan (Lions Gate Hospital, North Vancouver, Canada) ; Potretzke, Aaron (Mayo Clinic, Rochester, USA) ; Djaladat, Hooman (USC/Norris Comprehensive Cancer Center, Los Angeles, USA) ; Ghoreifi, Alireza (USC/Norris Comprehensive Cancer Center, Los Angeles, USA) ; Kikuchi, Eiji (St. Marianna University School of Medicine, Kawasaki, Japan) ; Hayakawa, Nozomi (St. Marianna University School of Medicine, Kawasaki, Japan) ; Mari, Andrea (Unit of Oncologic Minimally-Invasive Urology and Andrology (Florència, Itàlia)) ; Khene, Zine-Eddine (University of Rennes, Rennes, France) ; Fujita, Kazutoshi (Kindai University, Osaka, Japan) ; Raman, Jay D. (The Pennsylvania State University, Hershey, USA) ; Breda, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Fontana, Matteo (Institut d'Investigació Biomèdica Sant Pau) ; Sfakianos, John P. (Icahn School of Medicine at Mount Sinai, New York, USA) ; Pfail, John L. (Icahn School of Medicine at Mount Sinai, New York, USA) ; Laukhtina, Ekaterina (Sechenov University, Moscow, Russia) ; Rajwa, Pawel (Medical University of Silesia, Zabrze, Poland) ; Pallauf, Maximilian (University Hospital Salzburg, Salzburg, Austria) ; Cacciamani, Giovanni E. (University of Southern California, Los Angeles, USA) ; van Doeveren, Thomas (University Medical Center, Rotterdam, The Netherlands) ; Boormans, Joost L. (University Medical Center, Rotterdam, The Netherlands) ; Antonelli, Alessandro (University of Verona, Verona, Italy) ; Jamil, Marcus (Henry Ford Hospital, Detroit, USA) ; Abdollah, Firas (Henry Ford Hospital, Detroit, USA) ; Budzyn, Jeffrey (Henry Ford Hospital, Detroit, USA) ; Ploussard, Guillaume (La Croix du Sud Hospital, Toulouse, France) ; Heidenreich, Axel (University Hospital Cologne, Cologne Germany) ; Daneshmand, Siamak (USC/Norris Comprehensive Cancer Center, Los Angeles, USA) ; Boorjian, Stephen A. (Mayo Clinic, Rochester, USA) ; Rouprêt, Morgan (Sorbonne University, Paris, France) ; Rink, Michael (University Medical Center Hamburg-Eppendorf, Hamburg, Germany) ; Shariat, Shahrokh F. (Charles University, Prague, Czech Republic) ; Pradere, Benjamin (La Croix du Sud Hospital, Toulouse, France) ; Universitat Autònoma de Barcelona
Measuring the quality of care is important in health care to improve the treatment of patients. In this investigation, we sought to identify five indicators ("pentafecta") that reflect the quality of care of patients who have cancer of the upper urinary tract (kidney and/or ureter) and are treated with surgical removal of the affected kidney and ureter. [...]
2022 - 10.3390/cancers14071781
Cancers, Vol. 14 (march 2022)  
3.
11 p, 2.5 MB Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy : Systematic Review and Meta-Analysis / Krajewski, Wojciech (Wrocław Medical University (Wroclaw, Polònia)) ; Nowak, Łukasz (Wrocław Medical University (Wroclaw, Polònia)) ; Moschini, Marco (Luzerner Kantonsspital, Lucerne, Switzerland) ; Poletajew, Sławomir (Centre of Postgraduate Medical Education, Warsaw, Poland) ; Chorbińska, Joanna (Wrocław Medical University (Wroclaw, Polònia)) ; Necchi, Andrea (Fondazione IRCCS Ospedale San Raffaele (Milà, Itàlia)) ; Montorsi, Francesco (IRCCS Ospedale San Raffaele (Milà, Itàlia)) ; Briganti, Alberto (IRCCS Ospedale San Raffaele (Milà, Itàlia)) ; Sanchez-Salas, Rafael (Université Paris-Descartes, Paris, France) ; Shariat, Shahrokh F. (Charles University, Prague, Czech Republic) ; Palou, Juan ; Babjuk, Marek (Institut d'Investigació Biomèdica Sant Pau) ; Teoh, Jeremy Y. C. (The Chinese University of Hong Kong, Hong Kong) ; Soria, Francesco (San Giovanni Battista Hospital) ; Pradere, Benjamin (University Hospital of Tours, Tours) ; Ornaghi, Paola Irene (Luzerner Kantonsspital, Lucerne, Switzerland) ; Pawlak, Aleksandra (Wroclaw University of Environmental and Life Sciences, Wrocław, Poland) ; Dembowski, Janusz (Wrocław Medical University (Wroclaw, Polònia)) ; Zdrojowy, Romuald (Wrocław Medical University (Wroclaw, Polònia)) ; Universitat Autònoma de Barcelona
Background: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) with pelvic lymph-node dissection is the standard treatment for cT2-4a cN0 cM0 muscle-invasive bladder cancer (MIBC). [...]
2021 - 10.3390/jcm10040651
Journal of clinical medicine, Vol. 10 (february 2021)  
4.
15 p, 1.0 MB An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer / Soria, Francesco (San Giovanni Battista Hospital) ; Droller, Michael J. (The Mount Sinai Medical Center. Department of Urology) ; Lotan, Yair (University of Texas Southwestern Medical Center. Department of Urology) ; Gontero, Paolo (San Giovanni Battista Hospital) ; D'Andrea, David (Medical University of Vienna. Department of Urology and Comprehensive Cancer Center, Vienna General Hospital) ; Gust, Kilian M. (Medical University of Vienna. Department of Urology and Comprehensive Cancer Center, Vienna General Hospital) ; Rouprêt, Morgan (Assistance Publique-Hôpitaux de Paris Sorbonne Université. Department of Urology, Hôpital Pitié-Salpétrière) ; Babjuk, Marek (Medical University of Vienna. Department of Urology and Comprehensive Cancer Center, Vienna General Hospital) ; Palou, Juan (Institut d'Investigació Biomèdica Sant Pau) ; Shariat, Shahrokh F. (Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria) ; Universitat Autònoma de Barcelona
With the advent of novel genomic and transcriptomic technologies, new urinary biomarkers have been identified and tested for bladder cancer (BCa) surveillance. To summarize the current status of urinary biomarkers for the detection of recurrence and/or progression in the follow-up of non-muscle invasive BCa patients, and to assess the value of urinary biomarkers in predicting response to intravesical Bacillus Calmette-Guerin (BCG) therapy. [...]
2018 - 10.1007/s00345-018-2380-x
World Journal of Urology, Vol. 36 (june 2018) , p. 1981-1995  

See also: similar author names
1 Shariat, S.
11 Shariat, S.F.
1 Shariat, Shahrokh F
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.